Rigel Pharmaceuticals (RIGL) Enterprise Value (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.34% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | -26.54% |
| Jun 30, 2025 | -40.57% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | -26.52% |
| Sep 30, 2024 | -24.46% |
| Jun 30, 2024 | 0.90% |
| Mar 31, 2024 | 12.97% |
| Dec 31, 2023 | 8.69% |
| Sep 30, 2023 | 3.12% |
| Jun 30, 2023 | -9.71% |
| Mar 31, 2023 | -0.78% |
| Dec 31, 2022 | 28.71% |
| Sep 30, 2022 | 8.44% |
| Jun 30, 2022 | 17.07% |
| Mar 31, 2022 | 13.96% |
| Dec 31, 2021 | 12.70% |
| Sep 30, 2021 | 6.68% |
| Jun 30, 2021 | -289.85% |